Appealing USPTO Patent Rejections: PTAB and Federal Circuit

Patent applicants who receive a final rejection from a USPTO examiner are not without recourse. Two principal appellate pathways exist: an administrative appeal to the Patent Trial and Appeal Board (PTAB) and, if that fails, judicial review before the United States Court of Appeals for the Federal Circuit. Understanding how these mechanisms operate, what standards govern each forum, and where one route ends and another begins is essential for navigating the post-rejection phase of patent prosecution.

Definition and Scope

A USPTO patent rejection triggers appellate rights under Title 35 of the United States Code. Specifically, 35 U.S.C. § 134(a) grants applicants the right to appeal any adverse examiner decision to the Patent Trial and Appeal Board, the administrative tribunal housed within the USPTO. PTAB is composed of administrative patent judges (APJs) who review both procedural and substantive grounds of rejection.

If PTAB affirms the rejection, two further routes are available under 35 U.S.C. § 141: an appeal to the United States Court of Appeals for the Federal Circuit, or a civil action filed in the United States District Court for the Eastern District of Virginia under 35 U.S.C. § 145. The Federal Circuit route is a direct appellate review on the existing administrative record. The district court route allows new evidence but is used less frequently in practice.

The regulatory context for patent law that frames these appeals is grounded in the America Invents Act (AIA) of 2011, which restructured the former Board of Patent Appeals and Interferences into PTAB and expanded its jurisdiction to cover inter partes review and post-grant review proceedings alongside ex parte appeals.

How It Works

The appellate process from a USPTO rejection follows a structured sequence:

  1. Final Rejection Issued — The examiner issues a final rejection under 37 C.F.R. § 1.113, closing prosecution on the merits. The applicant has 3 months (extendable to 6 months with fee payment) to respond.

  2. Notice of Appeal Filed — The applicant files a Notice of Appeal to PTAB under 37 C.F.R. § 41.31, accompanied by the applicable fee set by the USPTO fee schedule. Filing must occur within the statutory period following the final rejection.

  3. Appeal Brief Submitted — Within 2 months of the Notice of Appeal, the applicant files an Appeal Brief under 37 C.F.R. § 41.37. This brief must identify the rejected claims, present the arguments against each ground of rejection, and cite evidence from the prosecution record. PTAB's Standard Operating Procedures govern formatting and content requirements.

  4. Examiner's Answer — The examiner files an Examiner's Answer within 2 months. If the answer introduces a new ground of rejection, the applicant may reopen prosecution or file a Reply Brief.

  5. Reply Brief (Optional) — The applicant may file a Reply Brief within 2 months of the Examiner's Answer under 37 C.F.R. § 41.41.

  6. Oral Hearing (Optional) — PTAB may grant an oral hearing upon request, governed by 37 C.F.R. § 41.47. Approximately 5% to 10% of ex parte appeals proceed to oral argument, according to PTAB's published statistics.

  7. PTAB Decision — PTAB issues a written decision affirming, reversing, or remanding the rejection. PTAB may also designate new grounds of rejection under 37 C.F.R. § 41.50(b).

  8. Federal Circuit Appeal — If PTAB affirms, the applicant may petition the Federal Circuit under 35 U.S.C. § 141. The Federal Circuit applies a deferential standard: it reviews legal conclusions de novo but reviews factual findings for substantial evidence, as established in In re Gartside, 203 F.3d 1305 (Fed. Cir. 2000).

Common Scenarios

35 U.S.C. § 101 Eligibility Rejections — Rejections based on patent-ineligible subject matter under Section 101 are among the most frequently appealed. PTAB evaluates these under the two-step Alice/Mayo framework. Because eligibility analysis involves legal questions, the Federal Circuit reviews such determinations de novo, making this an active area of appellate litigation particularly in software patent and biotechnology patent contexts.

35 U.S.C. § 103 Obviousness Rejections — Non-obviousness rejections are the most common ground for PTAB appeals. PTAB reviews the examiner's Graham v. John Deere factor analysis: the scope and content of prior art, differences between prior art and the claimed invention, the level of ordinary skill in the pertinent art, and objective indicia of non-obviousness. PTAB reverses obviousness rejections at meaningful rates when examiners fail to articulate a specific reason to combine prior art references.

35 U.S.C. § 102 Novelty Rejections — Novelty-based rejections require the examiner to identify a single prior art reference disclosing every element of the claimed invention. When anticipation is disputed, PTAB closely examines whether the examiner's citation actually discloses each claimed limitation.

Claim Interpretation Disputes — PTAB historically applied the "broadest reasonable interpretation" (BRI) standard during examination appeals. Following a rule change effective January 2019 (83 Fed. Reg. 51340), PTAB now applies the Phillips construction standard — the same standard used by federal district courts — in all AIA trial proceedings, though BRI still applies during examination-stage appeals.

Decision Boundaries

The choice between PTAB appeal, continued prosecution, and civil action involves distinct tradeoffs.

PTAB Appeal vs. Continuing Application — Filing a continuation application allows an applicant to pursue amended claims while a PTAB appeal remains pending. These are not mutually exclusive; both paths can run in parallel. However, PTAB will not consider claim amendments not present in the record — amendments require reopening prosecution.

Federal Circuit vs. District Court (§ 145 Action) — The district court route under 35 U.S.C. § 145 permits introduction of evidence not in the administrative record, which can be advantageous when the rejection turned on disputed technical facts. However, under Hyatt v. Hirshfeld, 998 F.3d 1347 (Fed. Cir. 2021), the Federal Circuit limited the scope of new evidence admissible in § 145 actions to evidence the applicant could not have introduced earlier without bad faith. The Federal Circuit route is faster and less costly but is constrained entirely to the prosecution record.

Scope of Review at Federal Circuit — The Federal Circuit does not conduct de novo review of all PTAB findings. Factual determinations — including what a prior art reference discloses and what a person of ordinary skill in the art would understand — receive substantial evidence deference. Legal conclusions, including claim construction and § 101 eligibility, receive de novo review. This asymmetry shapes how appellants frame their arguments on appeal.

PTAB Affirmance Rates — PTAB's publicly available statistics, compiled in annual reports published at USPTO.gov, indicate that PTAB affirms examiner rejections in full in roughly 50% to 60% of ex parte appeal decisions in recent fiscal years, with partial reversals occurring in approximately 15% of decided cases. These figures underscore that a meaningful proportion of appeals result in at least some claim allowance.

The full landscape of patent appellate practice connects to the broader patent law resources available on this site, covering prosecution, post-grant proceedings, and validity challenges.

References

Read Next

Patent Prosecution: Navigating USPTO Examination This page covers the mechanics of USPTO examination, the legal standards examiners apply, the procedural tools available to... Regulatory Context for Patent Law Code, administered primarily by the United States Patent and Trademark Office (USPTO). Section 101 Patent Eligibility: Abstract Ideas, Laws of Nature, and Alice § 101 determines whether an invention belongs to a category of subject matter that can be patented at all — a threshold...